Global Medical Sevoflurane Market Size, Share and Trends Analysis Report, By Type (Generic Drug and Original Drug), and By Application (Children and Adults) Forecast (2022-2028)

The global medical sevoflurane market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Sevoflurane is used to cause general anesthesia through inhalation before and during surgery. The global medical sevoflurane market is growing due to the rising prevalence of various disorders such as cancer, respiratory diseases, and gastrointestinal disorders as well as the increasing number of surgical procedures performed globally. According to an article published by American Medical in December 2021, around 905,444 surgical procedures were done in 2019 in the US alone. Several factors such as innovations in the inhalation devices and governmental support and awareness regarding the use of inhalation anesthetics are further boosting the market growth. Additionally, the development in the healthcare infrastructure with the supportive government initiatives is also boosting the growth of the global medical sevoflurane market.

Amongst all types, he generic drug segment is anticipated to hold the major share in the global medical sevoflurane market. Various generic approvals of medical sevoflurane and the availability of these drugs in the market at economical rates is expected to propel the growth of the generic medical sevoflurane market. Amongst geographical regions, the North American medical sevoflurane market is anticipated to hold the major share in the global medical sevoflurane market. This is due to the improved healthcare infrastructure of this region. The rising number of medical surgery cases along with the early adoption of new treatments in this region is also driving the growth of the market.

Some of the major players in the market include Piramal Enterprises Ltd., Mylan N.V., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and BOC Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and launches, to stay competitive in the market. For instance, in January 2020, Dechra Pharmaceuticals PLC acquired veterinary inhalant anesthetic products Isoflurane and Sevoflurane from Halocarbon, LLC.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Piramal Enterprises Ltd., Mylan N.V., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and BOC Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Medical Sevoflurane Market Report by Segment

By Type

• Generic Drug
• Original Drug

By Application

• Children
• Adults

Global Medical Sevoflurane Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa